Instituto De Investigación Hospital Universitario La Paz
Clinical trials sponsored by Instituto De Investigación Hospital Universitario La Paz, explained in plain language.
-
Could a common gout pill protect hearts in HIV?
Disease control Recruiting nowThis trial tests whether colchicine, an anti-inflammatory drug used for gout, can reduce inflammation in the coronary arteries of people with HIV who have high cardiovascular risk. Participants take either colchicine or a placebo daily for 96 weeks, and changes in artery inflamma…
Phase: PHASE2 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Engineered immune cells take on tough leukemia in kids
Disease control Recruiting nowThis early-stage trial is testing a type of immunotherapy called CAR T cells in children, adolescents, and young adults with acute lymphoblastic leukemia that has come back or not responded to standard treatments. The therapy involves taking the patient's own immune cells or dono…
Phase: PHASE1 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Gene test before kidney transplant could prevent drug dosing errors
Disease control Recruiting nowThis study tests whether checking a patient's genes before a kidney transplant can help doctors choose the best starting dose of the anti-rejection drug tacrolimus. About 114 adults on the transplant waiting list will be randomly assigned to either standard dosing or a dose based…
Phase: PHASE4 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Jun 26, 2026 16:21 UTC
-
Breathing in sedation: could a gas help ICU patients leave the ventilator faster?
Symptom relief Recruiting nowThis study tests whether giving sedation as a gas (isoflurane) instead of through an IV (propofol) helps critically ill patients on breathing machines recover faster. About 620 adults in the ICU who need deep sedation will be randomly assigned to one of the two methods. The main …
Phase: PHASE4 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC